The progress in molecular biomarkers of gliomas

Malignant glioma, a common form of central nervous system tumor, has a poor prognosis. The overall survival of these patients is as low as 12–14 months only. In general, the progress in personal precision medication has been gradually directed toward the molecular profiling of the tumors. Malignant...

Full description

Bibliographic Details
Main Authors: Jing Qi, Hongwei Yang, Xin Wang, Yanyang Tu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Cancer Translational Medicine
Subjects:
Online Access:http://www.cancertm.com/article.asp?issn=2395-3977;year=2016;volume=2;issue=4;spage=125;epage=129;aulast=Qi